“pancreatic-cancer” Archives

in
Entry Author Date Location
Bio Roundup: Barron Joins GSK, Sage Bounces Back, Valeant Dumps Addyi 11/10/17 National
Five Prime Shares Dive on Latest Hiccup For Cancer Immunotherapy Combos 11/07/17 San Francisco
New Rapamycin CEO Hired to Handle Funding, FDA Inflection Points 08/07/17 Texas
New San Diego Biotech Looks to Open Way for Anti-Cancer Drugs 05/03/17 San Diego
OncoMed Slashes Workforce After Two Clinical Trial Failures in Cancer 04/24/17 San Francisco
Bio Roundup: Trump’s Rx Silence, PCSK9 News, Amgen’s Migraines & More 11/18/16 National
Led by Former Lilly Exec, Apexian Out to Tackle Pancreatic Cancer 11/16/16 Indiana
Safety Issue Triggers Partial FDA Hold for Aduro Bio 10/24/16 San Francisco
Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More 10/07/16 National
Still Stuck Below IPO Price, Merrimack Restructures, CEO Resigns 10/03/16 Boston
Aduro Takes Hit On Pancreatic Cancer Trial Miss, But Shares Rebound 05/16/16 San Francisco
Texas Roundup: Rapamycin, SparkCognition, MolecularMatch, Rackspace 04/27/16 Texas
A New Coat Makes The Difference in Rapamycin’s Disease Prevention 04/26/16 Texas
Big Bucks, Tiny Bubbles: Ex-Biogen Exec’s Exosome Startup Nabs $80M 11/17/15 Boston
Houston’s Fannin Forms Company to Fight Inflammation-Induced Cancers 09/21/15 Texas
Credit Suisse Banker Takes on CFO Role at Merrimack 08/06/15 Boston
Exact Sciences Outlines Pipeline of Diagnostics for Deadliest Cancers 06/30/15 Wisconsin
East Coast Biotech Roundup: Flagship, SQZ, Epizyme, IPOs & More 06/26/15 Boston
East Coast Biotech Roundup: Agios, Vertex, Epizyme, Celldex, & More 11/21/14 Boston
Houston Biotech Firm Bellicum Pharmaceuticals Files for IPO 11/19/14 Texas
As Rival Sputters, FibroGen Heads to Nasdaq Via $146M IPO 11/14/14 San Francisco
East Coast Biotech Roundup: GliaCure, Civitas, T2, & More 09/29/14 Boston
Houston’s Bellicum Nets $55M to Boost Trials for Cancer Treatment 08/27/14 Texas
East Coast Biotech Roundup: NJ Blues, Genzyme, Amicus, Biogen & More 08/25/14 Boston
East Coast Biotech Roundup: Vertex, Cubist, Editas, Polaris, & More 06/27/14 Boston
Sanofi Punts Cancer Drug Back to Merrimack 06/19/14 Boston
With J&J Deals, Aduro’s Cancer Vaccines Have New Chance To Prove Worth 06/18/14 San Francisco
West Coast Biotech Roundup: NanoString, Sequenom/Agena, CIRM, & More 06/06/14 San Diego
East Coast Biotech Roundup: Concert, Merrimack, Vertex, & More 05/02/14 Boston
Merrimack Heads to FDA as Pancreatic Cancer Drug Succeeds in Phase 3 05/01/14 Boston
Page 1 of 2 next page »